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Interleukin 1 (ILl) activated mitogen-activated protein (MAP) kinase kinase in human gingival and foreskin fibroblasts and KB cells. Maximal 
activity was found in cytosolic extracts made after stimulating cells for l 5 min. On anion-exchange chromatography two differently charged forms 
of MAP kinase kinase were identified, both phosphorylated a kinase-defective mutant MAP kinase, and activated recombinant wild type MAP 
kinase to phosphorylate MBP. Both were inhibited by an antiserum to recombinant MAP kinase kinase and the less acidic form was identified 
on Western blotting as an antigen of -43 kDa. Indistinguishable forms were very much more strongly induced by phorbol myristate acetate (PMA). 
TNF had a similar effect to that of ILl. 
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1. INTRODUCTION 
Interleukinl (ILl) and tumour necrosis factor (TNF) 
induce mitogen-activated protein (MAP) kinase activity 
in some cell types [1-3]. Many agonists timulate this 
enzyme, and most either activate protein kinase C or 
signal via tyrosine kinase receptors [4-6]. The signalling 
mechanisms ofboth ILl and TNF are not understood. 
Their receptors are not tyrosine kinases, and several 
studies have shown they do not signal via PKC [1,7,8], 
although they do activate other serine and threonine 
kinases, including MAP kinase [1-3]. 
The two ubiquitous forms of MAP kinase, p42 and 
p44 (also known as extracellularly regulated kinases, 
ERK 2 and 1, respectively), are closely related proteins 
that are activated by phosphorylation f nearly adjacent 
tyrosine and threonine residues [4-6]. This is carried out 
by an upstream enzyme, MAP kinase kinase, which has 
been cloned and shown to have the dual specificity for 
phosphorylating both tyrosine and threonine [9-12]. 
The MAP kinase kinase is itself activated by phospho- 
rylation and there is increasing evidence that the kinase 
Raf is its major activator [13 16]. 
How ILl and TNF impinge on the MAP kinase sys- 
tem is unknown, so tracing this pathway upstream 
could cast light upon their signalling mechanisms. Here 
we show that they both induce two active forms of the 
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phorbol myristate acetate. 
MAP kinase kinase, and these are indistinguishable 
from those induced by the PKC activator, PMA. 
2. MATERIALS AND METHODS 
2. h Cell cultures 
Cells were cultured in Dulbecco's modified medium (DMEM) con- 
taining 10% foetal calf serum and maintained at 37°C in a humidified 
atmosphere of air with 5% CO2. Human fibroblasts were made from 
tissue taken at surgery and were used at passages 7-12. KB cells were 
from the European Collection of Animal Cell Cultures at Porton 
Down, UK. 
2.2, Reagents 
Human recombinant ILia and TNF~ were purified from extracts 
of E. coil expressing the proteins [7]. Wild type and the kinase-defec- 
tive mutant (Lys 52 --* Arg)p42 MAP kinase (ERK 2) were recombi- 
nant proteins purified from bacterial lysates [17]. The rabbit antisera 
to MAP kinase and MAP kinase kinase were made against a C- 
terminal synthetic peptide [18] and rabbit muscle recombinant GST 
fusion protein [19] respectively. Phorbol myristate acetate (PMA) my- 
elin basic protein (MBP), ATP, proteinase inhibitors and fl-glycero- 
phosphate were from Sigma. [z-nP]ATP (3200 Ci/mmol) and l~SI- 
labelled donkey anti-rabbit Ig antibody (50(~2000 Ci/mmol) were 
from Amersham International p c (Aylesbury, UK). Other chemicals 
for electrophoresis were from BDH (Poole, UK) or Fisons (Loughbor- 
ough, UK). 
2.3. Preparation and chromatography of cell extracts 
Fibroblasts grown in 175-cm 2flasks were used 4 days after eaching 
confluence. They were stimulated by adding ILl (20 ng/ml), TNF (100 
ng/ml) or PMA (100 ng/ml) to the culture medium and incubating for 
15 min, or other indicated times, at 37°C. Stimulated or unstimulated 
cells (6 flasks each) were washed 3 times in ice-cold phosphate-buff- 
ered saline, then scraped into ice cold buffer (2 ml/flask: 5 mM Tris- 
HCI, pH 8.5, 20 mM fl-glycerophosphate, 10 mM NaF, 0.5 mM 
EGTA, 0.5 mM EDTA). After addition of proteinase inhibitors (final 
concentrations: 10,uM E64, 1 mM orthophenanthroline, 1 mM phen- 
ylmethylsulphonyl fluoride) the cells were homogenized by passage 
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through 23-gauge (twice) and 26-gauge 3/8 (five times) needles. The 
homogenates were centrifuged at 100,000 xg  for 1 h at 4°C. The 
supernatants (cytosolic fractions) were kept on ice prior to chromato- 
graphy. 
Chromatography was done at room temperature ona 5/5 Mono Q 
column (Pharmacia Ltd., UK) equilibrated with a buffer containing 
20 mM Tris-HCl, pH 8.5, 20 mM fl-glycerophosphate, 10 mM NaF, 
0.5 mM EDTA, 0.5 mM EGTA, For time course xperiments extracts 
of cells were chromatographed by stepwise elution. Otherwise, lution 
was by a linear gradient of NaCI in the buffer (0-0.5 M over 30 ml). 
l-ml fractions were collected and stored at 4 ° C. 
2.4. Assay for MAP kinase 
MAP kinase was detected by the use of MBP (0.1 mg/ml) as sub- 
strate. The assay mixture consisted of 5 ,ul of substrate in H~O, 5 H1 
of sample and the reaction was started by adding 5 H1 of buffer of 150 
mM Tris-HC1 pH 7.4, 20 mM MgClz, 60 HM ATP containing 
[ynP]ATP (specific activity 1.7 ktCi/nmol). Mixtures were incubated 
for 20 min in 96-well microtitre plates at 30°C. The reactions were 
stopped by adding 5 HI of 4 x SDS sample buffer and the mixtures 
were loaded on to SDS-PAGE (12.5% acrylamide) and electrophore- 
sed [20]. Gels were stained for protein, dried and autoradiographed. 
For quantitation, Cerenkov emission of excised gel slices was meas- 
ured. 
2.5. Assay of MAP kinase kinase by phosphorylation .t"MAP kinase 
MAP kinase kinase was detected by the use of mutant MAP kinase 
(0.1 mg/ml) as substrate. This mutant is unable to bind ATP and 
undergoes no autophosphorylation which can complicate interpreta- 
tion of assays for MAP kinase kinase. The assay was performed as for 
MBR 
2.6. Assay of MAP kinase kinase by MAP kinase dependent pho,spho- 
rylation of MBP 
Coupled assays were performed to show that MAP kinase was 
activated, rather than simply phosphorylated. For these assays wild 
type MAP kinase was used together with MBP as substrates. The 
assays were performed exactly as described for assay of MAP kinase 
except hat the substrate solution contained 0.25 mg/ml wild type 
MAP kinase, and 0.25 mg/ml MBR 
2.7. Western blotting 
Fractions from Mono Q chromatography were run on SDS-PAGE 
(12.5% acrylamide), then transferred to nitrocellulose membranes 
(Bio-Rad). The membranes were probed with antiserum to MAP 
kinase kinase (1:500 dilution), followed by 125I-labelled second anti- 
body. Antibody staining was visualized by autoradiography. 
3. RESULTS 
The onset of activation of kinases in ILl-stimulated 
cells has generally been found to be quite slow, and 
optimum activity is usually observed between 5 and 15 
min after exposure to the cytokines [1,21,22]. In initial 
experiments he time course of activation of MAP ki- 
nase kinase was investigated in KB cells activated by 
either ILl or PMA. Extracts were partially purified by 
stepwise lution from a Mono Q column. This was nec- 
essary because the effect of ILl could not be seen above 
the background in unfractionated cytosol. Fig. 1 shows 
that the fractionated extracts of PMA-stimulated KB 
cells had very marked increased ability to phospho- 
rylate the MAP kinase substrate. This reached a maxi- 
mum of about 10-fold activation after 5 min of stimula- 
tion and declined slowly. By contrast, the effect of ILl 
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Fig. 1. Time course of MAP kinase kinase activation i  KB cells. KB 
cells were stimulated for the indicated times with PMA (<3) or ILl (A). 
Cell extracts were chromatographed on aMono Q column by stepwise 
elution and assayed for ability to phosphorylate he mutant MAP 
kinase. See section 2 for details. 
was relatively weak: a 2- to 3-fold increase by 15 min. 
Similar but less detailed experiments carried out on 
human gingivat fibroblasts with both stimulating agents 
gave comparable results. We therefore decided to 
analyse chromatographically and immunologically the 
MAP kinase kinase activity generated after 15 min of 
cell stimulation by either PMA or cytokine. 
Cytosolic extracts were prepared from resting or 
stimulated human gingival fibroblasts and chromato- 
graphed on a Mono Q column which was eluted with 
a salt gradient. The fractions were assayed for MAP 
kinase activity on MBP substrate and Fig. 2A shows 
that the peak of MBP-kinase activity in the middle of 
the gradient was increased in stimulated cells. PMA 
caused a larger stimulation (about 6-fold) than ILl 
(about 2.5-fold). Western blotting (data not shown) 
confirmed that p42 MAP kinase antigen was present in 
these fractions. This degree of stimulation was similar 
to that found previously in MRC5 fibroblasts [2]. 
The fractions were next assayed for MAP kinase ki- 
nase activity by mixing with unactivated recombinant 
wild type p42 MAP kinase, 20 HM ATP and MBE and 
measuring the phosphorylation f MBP as described in 
the Methods section. Fig. 2B shows that the fractions 
from resting cells had some MAP kinase kinase activity 
in an early-eluting peak, while those from PMA-stimu- 
lated cells showed an increase in this, and the appear- 
ance of a second later eluting peak of activity. Both 
peaks eluted earlier than the MAP kinase itself (Fig. 2B) 
and it can also be seen that the fractions containing 
activator had little intrinsic MBP kinase activity (Fig. 
2A). ILl activated the same two components, but had 
a much weaker effect on the second one than PMA (Fig. 
2B). The MAP kinase kinase was also detected irectly 
by its ability to phosphorylate he inactive mutant MAP 
kinase substrate. Fig. 3A (a) shows that only fraction 
9 from resting cells was able to phosphorylate he sub- 
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Fig. 2. MAP kinase and its activator (MAP kinase kinase) in Mono 
Q chromatography fractions of human gingival fibroblasts: effects of 
PMA and ILl. Confluent fibroblasts were treated for 15 min with 
vehicle (e), PMA (©), or ILl (z~). Cell extracts were chromatographed 
on a Mono Q column eluted with a salt gradient. Fractions were 
assayed (A) for MAP kinase activity on MBP substrate, and (B) for 
MAP kinase activator by adding recombinant wild type MAP kinase 
with MBE The experiment isa representative one of three. See section 
2 for details. 
strate. This activity was increased in fractions from both 
the PMA and IL l - s t imulated cells (Fig. 3A (c) and (b)). 
A later eluting component  was also seen in fract ion 13 
part icular ly after PMA treatment (Fig. 3A (c)). This 
second component  was only weakly act ivated by I L l .  
These two peaks of  kinase kinase corresponded to those 
detected by act ivat ion of  added MAP kinase shown in 
Fig. 2B. 
The Mono Q fractions were next electrophoresed and 
immuno-sta ined with the ant iserum to MAP kinase ki- 
nase (Fig. 3B). A 43 kDa band was detected in the 
fraction 9 of  resting and st imulated cells. This corre- 
sponded to the first peak o f  kinase kinase (Fig. 3A). It 
was not  possible to detect any similar antigen in the 
fractions of  the second peak. Nevertheless, the antise- 
rum was inhibitory to the activity of  both peaks (Fig. 
4), suggesting that the second component  was immunol-  
ogically related to the known MAP kinase kinase, 
These experiments were extended by examining re- 
sponses of  another type of  human fibroblast. Fig. 5 
shows that IL l  and PMA induced the two forms of  
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Fig. 3. MAP kinase kinase in Mono Q chromatography fractions of 
human gingival fibroblasts detected by (A) phosphorylation of mutant 
MAP kinase, or (B) Western blotting with antiserum. The Mono Q 
fractions were those shown in Fig. 2: (a) resting cells, (b) ILl, (c) PMA. 
(A) shows autoradiographs of mutant MAP kinase phosphorylated by 
the fractions, (B) shows autoradiographs of Western blots made with 
antiserum to MAP kinase kinase. See section 2 for details. 
MAP kinase kinase in foreskin f ibroblasts. We also 
tested the effect of  TNF,  which shares many biological 
actions with I L l ,  including activation of  MAP kinase 
[3]. Fig. 5 shows that it too induced the same two forms 
o f  MAP kinase kinase as I L l ,  and to a similar extent. 
As  in gingival f ibroblasts and KB cells PMA had a 
significantly greater effect than the cytokines. 
4. D ISCUSSION 
IL l ,  TNF  or PMA all induced MAP kinase kinase 
a b c d e f g h 
Fig. 4. Inhibition of MAP kinase kinase peaks from Mono Q chrom- 
atography by an antiserum. Peak fractions of MAP kinase kinase 
activity from Mono Q fractions of PMA- or ILl-stimulated human 
gingival fibroblasts as shown in Figs. 2 and 3 were preincubated with 
1120 dilution of rabbit antiserum to recombinant MAP kinase or 
preimmune serum, and then assayed for their ability to phosphorylate 
the mutant MAP kinase as described in section 2. A section of the 
autoradiograph showing phosphorylated substrate is shown. (a) and 
(b) are fraction 9 from PMA-stimulated cells; (c) and (d) fraction 9 
from ILl-stimulated cells; (e) and (f) are fraction 13 from ILl-stimu- 
lated cells; (g) and (h) are fraction 13 from PMA-stimulated cells. (a), 
(c), (e) and (g) were treated with antiserum, (b), (d), (0 and (h) were 
treated with pre-immune serum. 
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Fig. 5. MAP kinase kinase in Mono Q chromatography fractions of 
human foreskin fibroblasts detected by phosphorylation f mutant 
MAP kinase. The fibrobtasts were stimulated with (a) vehicle, (b) ILl, 
(c) TNF, or (d) PMA for 15 min. Cytosolic extracts were chromatogra- 
phed on a Mono Q Column extactly as described for Fig. 2. Fractions 
were assayed for ability to phosphorylate the mutant MAP kinase and 
autoradiographs of this are shown. 
activity that comprised two differently charged forms. 
The less acidic co-eluted with a 43 kDa antigen detected 
by the ant iserum to MAP kinase kinase. This antigen 
stained more strongly in fractions of  act ivated cells. The 
reason for this is unexplained, since all the antigen of  
resting or st imulated cells appeared to have bound to 
the column. The first peak is l ikely to correspond to the 
cloned enzyme. The second peak was inhibited by the 
ant iserum so it may represent a more active form of  this 
which was not generated in sufficient quant i ty to be 
detectable by Western blotting. Being the more acidic 
form, it might represent a higher phosphory lat ion state. 
Some workers have found two [23,24] and others one 
[25-27] form of  MAP kinase kinase. A second MAP 
kinase kinase 81% homologous to the first has been 
reported recently [28]. However, both enzymes were 
present in each of  the two forms separated by Mono Q 
chromatography.  
I L l  was a weaker inducer of  MAP kinase kinase 
activity than PMA in both types of  f ibroblast, and in 
KB cells. This was consistent with the weaker induction 
of  MAP kinase by IL l  than PMA found in the present 
work with gingival f ibroblasts and previously with 
MRC5 f ibroblasts [2]. In KB cells we have been unable 
to detect any significant activation of  MAP kinase by 
IL l  as judged by increase in MBP kinase activity in 
Mono Q fractions. 
I L l  and TNF  therefore appear to be relatively weak 
activators of  the MAP kinase pathway in cell lines. 
Whether  the pathway is more strongly act ivated in 
physiological situations, and is important  for genera- 
tion of  biological responses to the cytokines, remains to 
be seen. 
Recent evidence indicates that a major  act ivator of  
the kinase kinase is Ra f  [13151, and that Raf  can be 
directly activated by PKC [29]. Whether  the cytokines 
are activating Raf, or a similar kinase, remains to be 
seen. 
In conclusion, I L l  and TNF  impinge on the MAP 
kinase pathway at a level above the MAP kinase kinase, 
but the relatively weak effects of  the cytokines uggests 
that the MAP kinase system may not be central to their 
signall ing mechanism, and could be being activated by 
cross talk from other pathways. 
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